Covered recipient · General Payments record
KINLEY C WARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health
General Payments · PY2021
$311.64
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.64 | 17 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.90 | 6 |
| TherapeuticsMD, Inc. | $55.18 | 4 |
| Exeltis, USA Inc. | $34.61 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $23.22 | 1 |
| Avion Pharmaceuticals | $16.40 | 1 |
| Daiichi Sankyo Inc. | $15.63 | 1 |
| Organon LLC | $14.36 | 1 |
| Lupin Inc. | $14.34 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $311.64 | 17 |
Payment records · PY2021 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $11.50 | 01/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859567 | CMS |
| AbbVie Inc. | $48.90 | 02/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859571 | CMS |
| AbbVie Inc. | $15.87 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859575 | CMS |
| AbbVie Inc. | $17.91 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859579 | CMS |
| AbbVie Inc. | $21.50 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859583 | CMS |
| AbbVie Inc. | $22.22 | 06/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795859587 | CMS |
| Avion Pharmaceuticals | $16.40 | 04/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845427811 | CMS |
| Daiichi Sankyo Inc. | $15.63 | 04/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836281119 | CMS |
| Exeltis, USA Inc. | $22.17 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806195775 | CMS |
| Exeltis, USA Inc. | $12.44 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806195771 | CMS |
| Lupin Inc. | $14.34 | 03/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 796732685 | CMS |
| MAYNE PHARMA INC. | $23.22 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 849462821 | CMS |
| Organon LLC | $14.36 | 08/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 837226349 | CMS |
| TherapeuticsMD, Inc. | $13.48 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844966366 | CMS |
| TherapeuticsMD, Inc. | $14.40 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844966373 | CMS |
| TherapeuticsMD, Inc. | $13.62 | 03/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844966385 | CMS |
| TherapeuticsMD, Inc. | $13.68 | 06/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844966379 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.